Literature DB >> 23580930

Update on the Epidemiology of Melanoma.

Steven T Chen1, Alan C Geller, Hensin Tsao.   

Abstract

Cutaneous malignant melanoma (CMM) has been increasing steadily in incidence over the past 30 years. Recent studies have explored associations between CMM and varying physiologic risk factors, such as nevi or hair and eye color, in addition to historical features such as a personal history of nonmelanoma skin cancer (NMSC), childhood cancers, Parkinson's Disease, hormone exposure and family history of CMM. Genome-wide association studies have also uncovered many genetic determinants of CMM risk. Ultimately, ultraviolet (UV) radiation exposure remains the most important modifiable risk factor for CMM. Organ transplant recipients, and nonsteroidal anti-inflammatory usage may also play a role. While risk factors are important to identify, effective campaigns to reduce the burden of disease through early detection and prevention are essential. We present detailed data regarding these facets of care for the CMM patient, and provide an update on the epidemiology of CMM.

Entities:  

Keywords:  Cancer; Epidemiology; Genetics; Melanoma

Year:  2013        PMID: 23580930      PMCID: PMC3619431          DOI: 10.1007/s13671-012-0035-5

Source DB:  PubMed          Journal:  Curr Dermatol Rep        ISSN: 2162-4933


  64 in total

1.  Effects of altitude and latitude on ambient UVB radiation.

Authors:  D S Rigel; E G Rigel; A C Rigel
Journal:  J Am Acad Dermatol       Date:  1999-01       Impact factor: 11.527

2.  Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study.

Authors:  Emily Y Chu; Karolyn A Wanat; Christopher J Miller; Ravi K Amaravadi; Leslie A Fecher; Marcia S Brose; Suzanne McGettigan; Lydia R Giles; Lynn M Schuchter; John T Seykora; Misha Rosenbach
Journal:  J Am Acad Dermatol       Date:  2012-05-18       Impact factor: 11.527

3.  Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis.

Authors:  Jerry D Brewer; Leslie J Christenson; Amy L Weaver; Daniel C Dapprich; Roger H Weenig; Katherine K Lim; John S Walsh; Clark C Otley; Wida Cherikh; Joseph F Buell; E Steve Woodle; Christopher Arpey; Pamela R Patton
Journal:  Arch Dermatol       Date:  2011-07

4.  IRF4 variants have age-specific effects on nevus count and predispose to melanoma.

Authors:  David L Duffy; Mark M Iles; Dan Glass; Gu Zhu; Jennifer H Barrett; Veronica Höiom; Zhen Z Zhao; Richard A Sturm; Nicole Soranzo; Chris Hammond; Marina Kvaskoff; David C Whiteman; Massimo Mangino; Johan Hansson; Julia A Newton-Bishop; Veronique Bataille; Nicholas K Hayward; Nicholas G Martin; D Timothy Bishop; Timothy D Spector; Grant W Montgomery
Journal:  Am J Hum Genet       Date:  2010-06-17       Impact factor: 11.025

5.  Estimating the attributable fraction for cancer: A meta-analysis of nevi and melanoma.

Authors:  Catherine M Olsen; Heidi J Carroll; David C Whiteman
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-19

6.  Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types.

Authors:  C D Holman; B K Armstrong
Journal:  J Natl Cancer Inst       Date:  1984-07       Impact factor: 13.506

7.  Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure.

Authors:  E Matichard; P Verpillat; R Meziani; B Gérard; V Descamps; E Legroux; M Burnouf; G Bertrand; F Bouscarat; A Archimbaud; C Picard; L Ollivaud; N Basset-Seguin; D Kerob; G Lanternier; C Lebbe; B Crickx; B Grandchamp; N Soufir
Journal:  J Med Genet       Date:  2004-02       Impact factor: 6.318

8.  Spectrum of cancer risk among US solid organ transplant recipients.

Authors:  Eric A Engels; Ruth M Pfeiffer; Joseph F Fraumeni; Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Robert A Wolfe; Nathan P Goodrich; A Rana Bayakly; Christina A Clarke; Glenn Copeland; Jack L Finch; Mary Lou Fleissner; Marc T Goodman; Amy Kahn; Lori Koch; Charles F Lynch; Margaret M Madeleine; Karen Pawlish; Chandrika Rao; Melanie A Williams; David Castenson; Michael Curry; Ruth Parsons; Gregory Fant; Monica Lin
Journal:  JAMA       Date:  2011-11-02       Impact factor: 157.335

9.  A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use.

Authors:  M R Karagas; T A Stukel; J Dykes; J Miglionico; M A Greene; M Carey; B Armstrong; J M Elwood; R P Gallagher; A Green; E A Holly; C S Kirkpatrick; T Mack; A Østerlind; S Rosso; A J Swerdlow
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

Review 10.  Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis.

Authors:  Mathieu Boniol; Philippe Autier; Peter Boyle; Sara Gandini
Journal:  BMJ       Date:  2012-07-24
View more
  32 in total

Review 1.  Review of interventions to reduce ultraviolet tanning: Need for treatments targeting excessive tanning, an emerging addictive behavior.

Authors:  Jerod L Stapleton; Joel Hillhouse; Kristine Levonyan-Radloff; Sharon L Manne
Journal:  Psychol Addict Behav       Date:  2017-06-22

Review 2.  MicroRNAs in skin response to UV radiation.

Authors:  Deeba N Syed; Mohammad Imran Khan; Maria Shabbir; Hasan Mukhtar
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

3.  Age at first birth and melanoma risk: a meta-analysis.

Authors:  Zhengyong Li; Mingjin Gu; Ying Cen
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Screening for Melanoma in Men: a Cost-Effectiveness Analysis.

Authors:  Adewole S Adamson; Jamie A Jarmul; Michael P Pignone
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

5.  Sociocultural experiences, body image, and indoor tanning among young adult women.

Authors:  Jerod L Stapleton; Sharon L Manne; Kathryn Greene; Katie Darabos; Amanda Carpenter; Shawna V Hudson; Elliot J Coups
Journal:  J Health Psychol       Date:  2016-02-29

6.  Impact of Human Adipose Tissue-Derived Stem Cells on Malignant Melanoma Cells in An In Vitro Co-culture Model.

Authors:  Fabian Preisner; Uwe Leimer; Stefanie Sandmann; Inka Zoernig; Guenter Germann; Eva Koellensperger
Journal:  Stem Cell Rev Rep       Date:  2018-02       Impact factor: 5.739

7.  Effects of web-based intervention on risk reduction behaviors in melanoma survivors.

Authors:  Deborah J Bowen; Wylie Burke; Jennifer L Hay; Hendrika Meischke; Julie N Harris
Journal:  J Cancer Surviv       Date:  2014-11-26       Impact factor: 4.442

Review 8.  Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.

Authors:  K Karimi; T H Lindgren; C A Koch; Robert T Brodell
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

9.  Association of Delays in Surgery for Melanoma With Insurance Type.

Authors:  Adewole S Adamson; Lei Zhou; Christopher D Baggett; Nancy E Thomas; Anne-Marie Meyer
Journal:  JAMA Dermatol       Date:  2017-11-01       Impact factor: 10.282

10.  CXCR4 inhibition modulates the tumor microenvironment and retards the growth of B16-OVA melanoma and Renca tumors.

Authors:  Ruchi Saxena; Yan Wang; James W Mier
Journal:  Melanoma Res       Date:  2020-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.